Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",eosinophil quantity,,RS:0004633,SD-Fhem1+/+,male,0 days,3,,CMO:0000369,blood eosinophil count to total leukocyte count ratio,,,,1,%,0.1155,0.2,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104893,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",eosinophil quantity,,RS:0004633,SD-Fhem1+/+,female,0 days,3,,CMO:0000369,blood eosinophil count to total leukocyte count ratio,,,,2.1,%,0.5196,0.9,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104894,control condition